Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 3, 2003 - Issue 1
Submit an article Journal homepage
20
Views
0
CrossRef citations to date
0
Altmetric
Review

Cost of diabetes-related complications: current issues, future directions

Kent Summers Global Health Outcomes, Lilly Corporate Center, Drop Code 1834, Indianapolis, IN 46285, USA. [email protected]
&
Thomas J Songer Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 3512 Fifth Avenue, Room 205, Pittsburgh, PA 15213, USA. [email protected]
Pages 17-24 | Published online: 09 Jan 2014

References

  • Rubin RJ, Altman WM, Mendelson DN. Healthcare expenditures for people with diabetes mellitus, 1992.1 Gun. Endocrinol Metab. 78(4), 809A-809F (1994).
  • American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care 21 (2), 296–309 (1998).
  • Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20 (9), 1396–1406 (1997).
  • Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care 25(1), 23–29 (2002).
  • Brown JB, Nichols GA, Glauber HS, Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22 (7), 1116–1124 (1999).
  • Hodgson TA, Cohen AJ. Medical care expenditures for diabetes, its chronic complications and its comorbidities. Prey Med. 29(3), 173–186 (1999).
  • Ramsey SD, Newton K, Blough D, McCullough DK, Sandhu N, Wagner EH. Patient-level estimates of the cost of complications in diabetes in a managed-care population. PharmacoEconomics 16 (3), 285–295 (1999).
  • Harris MI. Chapter 1 Summary. In: Diabetes in America 2nd Edition. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Betheseda, MD, USA (NTH Pub. No. 95–1468), 1–13 (1995).
  • Harris MI, Zimmet P Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance. In: International Textbook of Diabetes Mellitus, 2nd Fdition. John Wiley & Sons, New York, NY, USA, 13–16 (1997).
  • Harris MI, Regal KM, Cowie CC etal. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults: the Third National Health and Nutritional Examination Survey, 1988–1994. Diabetes Care 21(4), 518–524 (1998).
  • Harris MJ. Epidemiologic studies on the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM). Gun. Invest. Med. 18(4), 231–239 (1995).
  • Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab. Res. Rev. 16, 230–236 (2000).
  • Green A, Patterson CC. Trends in the incidence of childhood onset diabetes in Europe 1989–98. Diabetologia 44\(Suppl. 3), B3-8 (2001).
  • Dokheel TM, for the Pittsburgh Diabetes Epidemiology Research Group. An Epidemic of Childhood Diabetes in the United States? Evidence from Allegheny County, Pennsylvania. Diabetes Care 16 (12), 1606–1611 (1993).
  • King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care 21(9), 1414–1431 (1998).
  • Jonsson B. The economic impact of diabetes. Diabetes Care 21 (Suppl. 3), C7-10 (1998).
  • O'Brien JA, Shomphe LA, Kavenagh PL, Raggio GSCD, Caro JJ. Direct medical costs of complications resulting from Type 2 diabetes in the US. Diabetes Care 21(7), 1122–1128 (1998).
  • Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in Type 2 diabetes mellitus. Arch. Intern. Med 159(16), 1873–1880 (1999).
  • Dawson KG, Comes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada, 1998. Diabetes Care 25(8), 1303–1307 (2002).
  • Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. Occup. Envir. Med. 41(10), 863–877 (1999).
  • Persson U. The indirect costs of morbidity in Type II diabetic patients. PharmacoEconomics 8 (Supp1.1), 28–32 (1995)
  • Songer TJ. Disability in Diabetes. In: Diabetes in America, 2nd Fation. National Diabetes Data Group. Harris ML, Stern MP Dorman JS, Bennett PH (Eris). N1H Pub. No. 95–1468, US Government Printing Office, Washington, DC, USA (1995).
  • Vital and Health Statistics. Current Estimates from the National Health Interview Survey Series 10, no. 200 (1996).
  • Roman SH, Harris MI. Management of diabetes mellitus from a public health perspective. Endocrinol Metab. Clin. North Am. 26 (3), 443–474 (1997) .
  • Laditka SB, Mastanduno MP, Laditka JN. Healthcare use of individuals with diabetes in an employer-based insurance population. Arch. Intern. Med 161,1301–1308 (2001).
  • Peele PB, Lave JR, Songer TJ. Diabetes in employer-sponsored health insurance. Diabetes Care 25,1964–1968 (2002).
  • Langa KM, Vijan S, Hayward RA etal. Informal caregiving for diabetes and diabetic complications among elderly Americans. J. Gerontol. 57B(3), S177—S186 (2002).
  • Klein BE, Klein R, Moss SE. Self-rated health and diabetes of long duration: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 21(2), 236–240 (1998).
  • Hirsch A, Bartholomae C, Volmer T Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Res. 9,207–218 (2000).
  • CDC Diabetes in Managed Care Work Group. Diabetes mellitus in managed care: complications and resource utilization. Am. Managed Care 7(5), 501–508 (2001).
  • Eastman RC. Neuropathy in Diabetes (Chapter 15). In: Diabetes in America, 2nd Edition. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, MD, USA, (NIH Pub No. 95–1468), 339–348 (1995).
  • Holzer SES, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin. Therapeutics 20(1), 169–181 (1998).
  • Ramsey SD, Newton K, Blough D etal. Incidence, outcomes and cost of foot ulcers in patients with diabetes. Diabetes Care 22(3), 382–387 (1999).
  • Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 23(9), 1333–1338 (2000).
  • Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from Type 2 diabetes in the US. Diabetes Care 25(3), 476–481 (2002).
  • Javitt JC, Wang F, McBean AM et al. The use of costs of physician services for ophthalmic surgical procedures in 1988 and 1991. Physician Services 27(7), 575–582 (1996).
  • Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. .11/filbank Quarterly70(2), 319–340 (1992)
  • Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2,120–126 (1979)
  • Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 21(1), 160–178 (1998).
  • Farquhar I, Sorkin A, Summers K, Weir E. Concomitant illnesses in patients with diabetes: mortality, morbidity, benefits of newer treatments and individual and societal costs. In: Research in Human Capital and Development, Vol. 14: Investing in health: The Social and Economic Benefits Of Healthcare Innovation. Farquhar I, Summers K, Sorkin A (Eds). Elsevier Science Ltd., Kicllington, Oxford, UK, 197–282 (2001).
  • Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America, 2nd Edition. Harris MI (Ed.). National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, MD, USA (NIH Pub No. 95–1468), 448 (1995).
  • Myddanen L, Kuusisto J, Pyorala K, Laalkso M. Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36,553–559 (1993).
  • Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before onset of clinical diabetes? /A/VIA 263,2893–2898 (1990).
  • Jick H, Terris BZ, Derby LE. Further validation of information recorded on a general practitioner based computerized data resource in the UK. Phannacoepidemiol Drug Safetyl, 347–349 (1992).
  • Brown JB, Nichols GA, Glauber HS. Case- control study of 10 years of comprehensive diabetes care. sternj Med. 172,85-90 (2000).

Website

  • CDC's Diabetes Program. Publications and Products. National Diabetes Fact Sheet. www.cdc.govidiabetesipubsifactsheet.htm Accessed January 21,2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.